1-5 of 5
Christoph W.M. Reuter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Modulation of Anthracycline-Induced Cytotoxicity by Targeting the Prenylated Prenylome in Myeloid Leukemia Cells

Michael A Morgan, PhD, Fredrick O Onono, Peter H Spielmann, Thangaiah Subramanian, Michaela Scherr, Letizia Venturinin, Iris Dallmann, Arnold Ganser, MD, Christoph W.M. Reuter
Journal: Blood
Blood (2011) 118 (21): 1418.
https://doi.org/10.1182/blood.V118.21.1418.1418
Published: 2011
Journal Articles

Potentiation of Topoisomerase II Inhibitor-Mediated Myeloid Leukemia Cell Kill by Farnesyltransferase Inhibitor L-744,832.

Fredrick O. Onono, MSc, Michael A. Morgan, PhD, Jeanny Wegner, MD, Arnold Ganser, MD/PhD, Christoph W.M. Reuter, MD/PhD
Journal: Blood
Blood (2007) 110 (11): 3479.
https://doi.org/10.1182/blood.V110.11.3479.3479
Published: 2007
Journal Articles

Characterization of a Novel R-RAS Mutation Cloned from Primary AML Cells.

Christoph W.M. Reuter, MD, PhD, Erdem Aydilek, MD, Fredrick O. Onono, Michael A. Morgan, PhD, Kristine A. Henningfeld, PhD, Arnold Ganser, MD/PhD
Journal: Blood
Blood (2006) 108 (11): 1439.
https://doi.org/10.1182/blood.V108.11.1439.1439
Published: 2006
Journal Articles

Prenylation Inhibitors Block IL-6 and IGF-1 Dependent Activation of RAS Signaling in Multiple Myeloma Cells.

Christoph W.M. Reuter, MD, PhD, Michael A. Morgan, PhD, Dietrich Peest, MD/PhD, Arnold Ganser, MD/PhD
Journal: Blood
Blood (2005) 106 (11): 3373.
https://doi.org/10.1182/blood.V106.11.3373.3373
Published: 2005
Journal Articles

Targeting RAS Signaling in Multiple Myeloma (MM): Synergistic Inhibition by Co-Treatment with the MEK Inhibitor U0126 and Prenylation Inhibitors.

Christoph W.M. Reuter, MD/Ph.D., Michael A. Morgan, Ph.D., Tarkan Sebil, Arnold Ganser, MD/Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3398.
https://doi.org/10.1182/blood.V104.11.3398.3398
Published: 2004